Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 26.87% is 94% above its 5-year average of 13.86%, near the high end of its 5-year range (4.37%–26.95%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.94% above its 12-month average of 25.86%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 26.87%.
DEBT TO ASSETS RATIO
26.87%
DEBT TO ASSETS RATIO AVG TTM
25.86%
DEBT TO ASSETS RATIO AVG 3Y
19.38%
DEBT TO ASSETS RATIO AVG 5Y
13.86%
DEBT TO ASSETS RATIO AVG 10Y
8.48%
DEBT TO ASSETS RATIO AVG 15Y
7.61%
DEBT TO ASSETS RATIO AVG 20Y
15.69%
CURRENT VS TTM AVG
+3.94%
CURRENT VS 3Y AVG
+38.66%
CURRENT VS 5Y AVG
+93.87%
CURRENT VS 10Y AVG
+216.82%
CURRENT VS 15Y AVG
+253.09%
CURRENT VS 20Y AVG
+71.33%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+29760.46%
vs the sector median at left
Orthofix Medical Inc.
Market Cap
$383.11M
Debt to Assets Ratio
26.87%
TTM Avg
25.86%
3Y Avg
19.38%
5Y Avg
13.86%
Market Cap
$377.81M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$377.32M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$376.11M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$376.10M
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$364.83M
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$404.92M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $383.11M | 26.87% | 25.86% | 19.38% | 13.86% |
| Zura Bio Limited (ZURA)vs › | $382.37M | 0.00% | N/A | N/A | N/A |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $377.81M | 0.15% | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $377.32M | 0.10% | N/A | N/A | N/A |
| YD Bio Limited Ordinary Shares (YDES)vs › | $376.11M | 0.00% | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $376.10M | 0.25% | N/A | N/A | N/A |
| REGENXBIO Inc. (RGNX)vs › | $394.44M | 0.18% | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $364.83M | 0.38% | N/A | N/A | N/A |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $404.92M | 0.00% | N/A | N/A | N/A |
| Carlsmed, Inc. (CARL)vs › | $406.41M | 0.19% | N/A | N/A | N/A |
Debt/Assets
26.9%
Debt/Equity
0.55
Current Ratio
2.84
Interest Coverage
-3.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 26.87% |
| 2026-03-31 | 26.44% |
| 2025-12-31 | 26.95% |
| 2025-09-30 | 24.56% |
| 2025-06-30 | 24.46% |
| 2025-03-31 | 23.42% |
| 2024-12-31 | 20.11% |
| 2024-09-30 | 15.81% |
| 2024-06-30 | 15.52% |
| 2024-03-31 | 15.15% |
| 2023-12-31 | 12.65% |
| 2023-09-30 | 9.87% |
| 2023-06-30 | 10.15% |
| 2023-03-31 | 7.06% |
| 2022-12-31 | 4.69% |
| 2022-09-30 | 4.46% |
| 2022-06-30 | 4.37% |
| 2022-03-31 | 4.40% |
| 2021-12-31 | 5.10% |
| 2021-09-30 | 4.52% |
| 2021-06-30 | 4.53% |
| 2021-03-31 | 4.44% |
| 2020-12-31 | 4.74% |
| 2020-09-30 | 4.44% |
| 2020-06-30 | 20.64% |
| 2020-03-31 | 4.63% |
| 2019-12-31 | 4.61% |
| 2019-09-30 | 4.43% |
| 2019-06-30 | 4.33% |
| 2019-03-31 | 4.43% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 4.61% |
| 2014-03-31 | 4.78% |
| 2013-12-31 | 4.68% |
| 2013-09-30 | 4.65% |
| 2013-06-30 | 4.35% |
| 2013-03-31 | 3.97% |
| 2012-12-31 | 3.97% |
| 2012-09-30 | 3.59% |
| 2012-06-30 | 7.32% |
| 2012-03-31 | 29.17% |
| 2011-12-31 | 30.19% |
| 2011-09-30 | 32.58% |
| 2011-06-30 | 33.40% |
| 2011-03-31 | 34.37% |
| 2010-12-31 | 36.43% |
| 2010-09-30 | 37.68% |
| 2010-06-30 | 38.91% |
| 2010-03-31 | 39.79% |
| 2009-12-31 | 43.13% |
| 2009-09-30 | 44.51% |
| 2009-06-30 | 46.75% |
| 2009-03-31 | 48.93% |
| 2008-12-31 | 50.39% |
| 2008-09-30 | 51.47% |
| 2008-06-30 | 33.44% |
| 2008-03-31 | 33.83% |
| 2007-12-31 | 34.62% |
| 2007-09-30 | 34.51% |
| 2007-06-30 | 35.67% |
| 2007-03-31 | 35.87% |
| 2006-12-31 | 36.59% |
| 2006-09-30 | 37.79% |
| 2006-06-30 | 0.81% |
| 2006-03-31 | 0.04% |
| 2005-12-31 | 3.23% |
| 2005-09-30 | 10.69% |
| 2005-06-30 | 14.44% |
| 2005-03-31 | 16.16% |
| 2004-12-31 | 17.95% |
| 2004-09-30 | 21.84% |
| 2004-06-30 | 24.97% |
| 2004-03-31 | 26.01% |
| 2003-12-31 | 26.67% |
| 2003-09-30 | 1.53% |
| 2003-06-30 | 1.31% |
| 2003-03-31 | 2.60% |
| 2002-12-31 | 3.36% |
| 2002-09-30 | 3.19% |
